Page 28 of 32 · 745 questions tagged clinical-trials.
Details up front: STEP 1 · early satiety. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at anyone else’s…
What I am working with: tirzepatide · liraglutide. I am trying to choose between two options that are usually discussed as though only one exists. I am not optimising…
I have the full paper rather than the abstract, and the supplementary appendix. I can predict the outcome but I cannot explain it, which means I will get the next…
Numbers first: 8 mg · retatrutide. I would rather over-plan the first cycle and simplify later. I am prepared to do the work if someone can tell me which work…
This is a question about interpretation, not about whether to act — I will take action questions elsewhere. I keep seeing this stated as a fact with no explanation…
I have three DEXA scans on the same scanner at twelve-week intervals, fasted, same time of day. I would like to know whether this claim survives contact with…
For reference: liraglutide · minus 80 °C. I would like to know whether this claim survives contact with evidence. If the answer is "nobody has tested that", I would…
Stated plainly: ESSENCE · early satiety. I have the document in front of me and I can read the numbers. What I cannot do is interpret them. I am reasonably…
I would like to know how much of this is established and how much is a reasonable story. I want to know what the trade-off actually is rather than which option is…
The particulars: STEP 4 · early satiety · 1 mg. I want to understand what this actually establishes, as opposed to what it is being used to imply. My concern is that…
What I have: ESSENCE · hair thinning · 2 mg. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear to…
The case in front of me: SURMOUNT-5 · dizziness · 10 mg. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading…
I have three data points across nine months, which I hope is enough to see a trend. I would like the arithmetic checked rather than the conclusion asserted. I have…
Conditions: semaglutide · ESSENCE. I understand the observation; what I do not understand is the mechanism behind it. I have read the two review articles that come up…
Conditions: SURMOUNT-3 · tirzepatide. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the specifics…
The specifics, since they change the answer: tirzepatide · 2–8 °C. I would like to know whether this claim survives contact with evidence. If the answer is "nobody…
The particulars: SUSTAIN-6 · early satiety. I have the document in front of me and I can read the numbers. What I cannot do is interpret them. I am reasonably…
My laboratory results are from the same laboratory each time, drawn fasting, which I gather matters. The empirical answer seems settled. The explanation does not. If…
What I am working with: ecnoglutide · tirzepatide. I would like the axes of comparison first and the recommendation second. I have tried the first option and it…
What I am working with: SELECT · dizziness · 2 mg. I have read the primary source rather than the summary, which has left me with more questions. I understand the…
Setup, so nobody has to ask: REDEFINE-1 · cagrilintide. This is asserted often enough that I assumed it was established, and then I went looking for the source. I…
Stated plainly: SURMOUNT-5 · reflux · 15 mg. I would like help reading this properly rather than being told what conclusion to reach. I have the full report including…
Setup, so nobody has to ask: SURMOUNT-5 · reflux. I would like help reading this properly rather than being told what conclusion to reach. I have the full report…
The case in front of me: TRIUMPH-3 · fatigue · 12 mg. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if…